SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-049559
Filing Date
2020-04-22
Accepted
2020-04-22 09:29:34
Documents
3
Period of Report
2020-04-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2016592-1_8k.htm 8-K 31415
2 EXHIBIT 10.1 tm2016592d1_ex10-1.htm EX-10.1 123670
3 EXHIBIT 10.2 tm2016592d1_ex10-2.htm EX-10.2 131719
  Complete submission text file 0001104659-20-049559.txt   288099
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 20806812
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences